z-logo
open-access-imgOpen Access
Spry2 is a novel therapeutic target for periodontal tissue regeneration through fibroblast growth factor receptor signaling and epidermal growth factor signaling
Author(s) -
Terukazu Sanui,
Takao Fukuda,
Urara Tanaka,
Kyosuke Toyoda,
Takaharu Taketomi,
Fusanori Nishimura
Publication year - 2015
Publication title -
receptors and clinical investigation
Language(s) - English
Resource type - Journals
ISSN - 2330-0566
DOI - 10.14800/rci.597
Subject(s) - regeneration (biology) , epidermal growth factor , fibroblast growth factor , growth factor receptor inhibitor , microbiology and biotechnology , epidermal growth factor receptor , cancer research , fibroblast growth factor receptor 2 , fibroblast growth factor receptor , tissue repair , signal transduction , growth factor , receptor , biology , growth factor receptor , medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here